Advance Paradigm's "Therapeutic MAC" Program Cuts Rx H2 Costs By 15%
Executive Summary
Advance Paradigm's "therapeutic MAC" program at a west coast health care plan cut the overall cost of prescription drugs by more than 15% percent in the H2 blocker category after one quarter of operation, VP-Trade Relations Karl Schumann said at the annual Generic Pharmaceutical Industry Association meeting in New York City March 14.